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The Journal of Immunology
Accelerated Turnover of MHC Class II Molecules in
Nonobese Diabetic Mice Is Developmentally and
Environmentally Regulated In Vivo and Dispensable for
Autoimmunity
Alessandra De Riva,* Mark C. Varley,*,† Leslie J. Bluck,‡ Anne Cooke,x
Michael J. Deery,{ and Robert Busch*
The H2-Ag7 (Ag7) MHC class II (MHCII) allele is required for type 1 diabetes (T1D) in NOD mice. Ag7 not only has a unique
peptide-binding profile, it was reported to exhibit biochemical defects, including accelerated protein turnover. Such defects were
proposed to impair Ag presentation and, thus, self-tolerance. Here, we report measurements of MHCII protein synthesis and
turnover in vivo. NOD mice and BALB/c controls were labeled continuously with heavy water, and splenic B cells and dendritic
cells were isolated. MHCII molecules were immunoprecipitated and digested with trypsin. Digests were analyzed by liquid
chromatography/mass spectrometry to quantify the fraction of newly synthesized MHCII molecules and, thus, turnover. MHCII
turnover was faster in dendritic cells than in B cells, varying slightly between mouse strains. Some Ag7 molecules exhibited
accelerated turnover in B cells from young, but not older, prediabetic female NOD mice. This acceleration was not detected in
a second NOD colony with a high incidence of T1D. Turnover rates of Ag7 and H2-Ad were indistinguishable in (NOD 3 BALB/c)
F1 mice. In conclusion, accelerated MHCII turnover may occur in NOD mice, but it reflects environmental and developmental
regulation, rather than a structural deficit of the Ag7 allele. Moreover, this phenotype wanes before the onset of overt T1D and
is dispensable for the development of autoimmune diabetes. Our observations highlight the importance of in vivo studies in
understanding the role of protein turnover in genotype/phenotype relationships and offer a novel approach for addressing this
fundamental research challenge. The Journal of Immunology, 2013, 190: 5961–5971.
N
onobese diabetic mice have been studied extensively as a
paradigmof complex autoimmune disease, which develops
under the control of genetic, hormonal, and environmental
influences. Lymphocyte infiltration of pancreatic islets develops at
a young age, leading to progressive b cell destruction and, starting
around 12 wk of age, to overt type 1 diabetes (T1D), with a female
sex bias (1). Genetic control of T1D in NOD mice includes critical
contributions from both H2-A and H2-EMHC class II (MHCII) loci,
alongside multiple non-MHCII genes, most of which affect T cell
function (2, 3). NOD mice lack Ea transcription; in addition, the
unique H2-Ag7 (Ag7) b-chain differs by 17 aa from the protective
Abd allele (4). T1D development is reduced or abrogated in NOD
mice transgenic for Ea or other H2-A alleles (3). MHCII glyco-
proteins normally present peptides to CD4+ T lymphocytes, and
NOD mice harbor pathogenic CD4+ effector T cells that recognize
islet autoantigens presented by Ag7 (reviewed in Ref. 5). Abg7 shares
key polymorphisms, in particular a non-Asp residue at position 57,
and peptide-binding preferences with human HLA-DQB1 alleles
that confer risk for T1D (6–8). Nonetheless, no unifying explanation
for the link between these alleles and islet autoimmunity has
emerged from considerations of peptide-binding specificity (5).
Moreover, the potential for Ag7-restricted T cell autoreactivity
extends to self-Ags that are systemically expressed, both in the
“autoproliferation” phenotype of NOD mice (9, 10) and in the K/
B3N model of autoimmune arthritis (11, 12). These considerations
prompted suggestions that Ag7 confers a broader tendency toward
autoreactivity, perhaps mediated by unique biochemical properties
other than their peptide-binding specificity.
Indeed, Ag7 exhibits several unusual biochemical properties
compared with other MHCII alleles (5). Many MHCII alleles re-
main stable as ab heterodimers in SDS at room temperature when
loaded stably with peptides, but Ag7 dimers readily dissociate
under these conditions (13). Genetic studies indicate that this
relative instability represents an intrinsic structural property of the
Ag7 heterodimer. SDS instability also correlates with the T1D risk
or protection associated with human DQ alleles (14). In [35S]-
pulse/chase experiments performed in vitro, Ag7 exhibited faster
turnover in cultured NOD splenocytes than did other H2-A alleles
in splenocytes from other mouse strains (13). Based on these
observations, it was proposed that a biochemical stability defect of
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Ag7, leading to accelerated turnover, might impair T cell tolerance
(9, 10).
This view has been controversial, however. SDS instability is
shared by other H2-A alleles, which are not associated with
spontaneous autoimmunity; Ag7 may be at the lower end of normal
allelic variation in this regard (5, 15). Initial evidence that SDS
instability was attributable to poor peptide binding by Ag7 (13)
was not borne out by subsequent peptide-binding and extraction
studies (5). Moreover, several HLA-DQ alleles that confer risk
for T1D in humans retain peptides well, despite interacting poorly
with HLA-DM during endosomal peptide loading (5). Structural
studies in which Ag7 was expressed and crystallized did not in-
dicate any marked defects in stability or folding (16).
More recent studies showed that MHCII protein life span is
affected by extrinsic variables. Wild-type APCs of different line-
ages vary in their MHCII-internalization rates, correlating with
the length of ubiquitin chains attached to MHCII b-chains (17).
Ubiquitination is modulated during activation of dendritic cells
(DCs) by proinflammatory stimuli in vitro (18), correlating with
large differences in MHCII protein life span (19). Genetic defi-
ciency in the peptide-exchange cofactor, DM, reduces the surface
expression of Ag7 and other MHCII alleles with low affinity for
invariant chain peptides and increases their turnover (20, 21).
Similar effects on MHCII life span could result from negative
regulation of DM activity by HLA-DO/H2-DO (22), which is
differentially expressed during APC development (23–25). In
NOD mice, MHCII associations with invariant chain may be ab-
normal, and the development and frequencies of B cells and DCs
were reported to be altered, with unknown consequences for the
regulation of MHCII protein life span (5).
Moreover, T1D development is subject to environmental control.
In NOD colonies worldwide, T1D incidence varies between from
∼20 to $80% in females at 30 wk of age (26), suggesting that
diabetes development is influenced by environmental and epige-
netic factors. Environmental factors that contribute to this varia-
tion include multiple viral, bacterial, and eukaryotic pathogens;
the resident intestinal microflora; as well as experimentally ad-
ministered proinflammatory stimuli, all of which modify host
immune responsiveness (27). In addition, hormonal regulation is
suggested by the much lower disease incidence in males; this, too,
is influenced by the microbiome (28). Whether disease-relevant
environmental factors affect MHCII protein life span in vivo
remains unclear.
A definitive assessment of the determinants of MHCII protein
instability and its role in autoimmune pathogenesis requires quan-
tification of turnover rates in vivo in APCs of living animals.
Methodologies for addressing this problem have been lacking until
recently. Radiolabeling, a standard approach for measuring protein
life span invitro (29), is difficult to use invivo. Stable isotope labeling
of amino acids in cell culture (SILAC) has been applied in vivo, but
complete labeling of proteins with essential amino acids takes sev-
eral generations in mice (30), and the precursor/product relationships
are not well understood in vivo. Stable isotope approaches have been
used for proteome-wide surveys of steady-state protein expression
levels and for kinetic proteomics; in contrast, little work has focused
on assessing the effects of structural polymorphism on the turnover
rates of specific proteins of interest.
We (31, 32) and, independently, other investigators (33, 34)
developed an alternative approach to address this problem: stable
isotope labeling of nonessential amino acids with heavy water
(SINEW). We showed that this approach can be used to quantify
the biosynthetic dynamics of different MHC allotypes (31). Deu-
terated water (heavy water, 2H2O) is used as a nonradioactive
metabolic tracer, which does not interfere detectably with normal
physiology at the concentrations used for labeling (35). Following
2H2O administration,
2H equilibrates rapidly across body water
pools and is incorporated biosynthetically into nonessential amino
acids and, hence, into proteins of interest (31, 32), with minimal
and transient interference from dietary amino acids (32, 36). The
approach is now well-validated for quantification of protein syn-
thesis on time scales of a few hours or longer. In this study, we
applied SINEW to characterize MHCII turnover in vivo. Surpris-
ingly, our findings indicate that environmental and developmental
variables, rather than structural polymorphism, are key determi-
nants of accelerated turnover of Ag7 in NOD APCs and that this
phenotype is dispensable for development of T1D.
Materials and Methods
Mice and cell lines
Animal studies were performed according to institutional and national
guidelines under UK Home Office Project Licenses 80/2156 and 80/2440.
For most studies, NOD mice (named “NODlow” where necessary to avoid
ambiguity) were bred under specific pathogen–free conditions at the
Centre for Biomedical Services, University of Cambridge, from founder
stock kindly provided by Prof. Linda Wicker. NOD genotype (100%) was
authenticated in a breeding trio using an array of 384 single nucleotide
polymorphisms (Charles River Laboratories), spaced ∼7 MB apart across
the entire genome, which distinguish common inbred mouse strains.
BALB/c mice were purchased from Charles River Laboratories and used
after 10 d of acclimatization in the same facility. Female BALB/c mice
were bred with NOD males to generate F1 mice. Animals were maintained
in individually ventilated cages and received standard rodent chow and
water ad libitum.
A second colony of NOD mice (named “NODhigh”) was bred in the
animal facility of the Department of Pathology, University of Cambridge,
and maintained under barrier conditions. These NOD mice were also de-
rived from founder stock kindly provided by Prof. Linda Wicker in 2002.
T1D incidence increased over time in the facility in the Department of
Pathology and subsequently remained high ($80% by 30 wk of age in
females).
Both colonies were maintained by breeding the first litter in each gen-
eration and were kept on the same diet. For incidence studies, animals were
aged to 30 wk and observed regularly for signs of diabetes; incidence was
confirmed bymeasurement of glucosuria, usingDiastix (BayerDiagnostics).
Routine veterinary microbiological screening of sentinel mice in both col-
onieswas carried out to a standard exceeding current recommendations of the
Federation of European Laboratory Animal Sciences Associations (B&K
Diagnostics).
M12.NOD is a derivative of the M12 murine B lymphoma cell line
transfected with Ag7 genes. These cells, as well as murine A20 B lymphoma
cells and the EBV-transformed B cell line, Priess, were cultured as previ-
ously described (31).
Labeling experiments
Mice were labeled to 4–5 atom percent enrichment (a.p.e.) of 2H2O in body
water by initial i.p. bolus injection of 35 ml/kg 99% a.p.e. 2H2O (CK Gas)
containing 0.9% w/v NaCl. This material was depleted of LPS using
Detoxi-Gel Columns (Thermo Scientific) and sterile filtered. The initial
body water enrichment was maintained by continuous administration of
8% a.p.e. 2H2O in drinking water ad libitum. Control animals received
injections of LPS-depleted 0.9% (w/v) NaCl in natural-abundance water
and were maintained concurrently. At various time points following i.p.
bolus, animals were exsanguinated under terminal general anesthesia, and
spleens and femurs were removed following cervical dislocation.
Abs
MK-D6 (IgG2a anti–H2-Ad) (37) and 14.4.4S (IgG2a anti–H2-E) (38)
hybridomas were kind gifts from Dr. B. Stockinger. ME-1 (IgG1 anti–
HLA-B27) (39) and W6/32 (IgG2a anti–HLA-A/-B/-C) (40) were kindly
provided by Prof. J.S.H. Gaston and used as isotype controls. The mAbs
were used as culture supernatants or purified over protein A or protein G
affinity columns (GE Biosciences). For flow cytometry, MK-D6 was FITC
labeled using Lightning-Link Fluorescein (Innova Biosciences). Other Abs
(developed in mice, unless mentioned otherwise) were obtained commer-
cially: IgG1-FITC isotype control, clone MOPC21, from BD Biosciences;
IgG2a-FITC isotype control, cat no. MG2A01, from Invitrogen; and
CD19-PE/Cy5, clone eBio1D3, and rat anti-mouse CD86-PE, clone PO3.1,
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from eBioscience. The following Abs were from BioLegend: CD11c-
allophycocyanin, clone N418; OX-6 anti-RT1.B, cross-reactive with
H2-Ag7, unconjugated and FITC-conjugated; anti–H2-Ad/g7 (Ad/g7)–Alexa
Fluor 647, clone 39-10-8; rat IgG2b-PE, clone RTK 530; and IgG3–Alexa
Fluor 647 isotype control, clone MG3-35.
Cell isolation and flow cytometry
Spleens were disrupted mechanically after enzymatic dissociation with
Liberase CI (Roche), following the manufacturer’s instructions. After in-
cubation in mouse FcR blocking Reagent (Miltenyi Biotec), CD11c+ and
B220+ cells were sequentially isolated by immunomagnetic labeling with
CD11c and CD45R(B220) MACS MicroBeads (Miltenyi Biotec) and
double-positive selection using an AutoMACS magnetic cell sorter
(Miltenyi Biotec), following the manufacturer’s instructions. Cell isolations
were monitored by staining aliquots with fluorochrome–Ab conjugates
against CD11c, CD19, and MHCII or isotype controls. Analysis was per-
formed using a FACSCanto II flow cytometer (BD Biosciences) and FlowJo
software (TreeStar). B cells and DCs were enumerated as CD19+MHCII+
and CD11c+MHCII+, respectively, after gating on intact splenocytes by
forward and side scatter. MHCII and CD86 levels (median fluorescence
intensities) were quantified after gating on cells expressing the appropriate
lineage Ag within the scatter gate. Purified cell samples were washed in
PBS, counted, and stored as pellets at 220˚C.
Protein isolation
Cell pellets were extracted in ice-cold TBS (pH 7.4) containing 1% IGEPAL
CA-630 (Sigma) and protease inhibitors (Complete; Roche; plus 10 mM
iodoacetamide). Extracts were centrifuged at 10,0003 g to pellet nuclei and
debris (stored at 220˚C for subsequent DNA analysis, see below), and the
supernatants were precleared and immunoprecipitated with appropriate anti-
MHCII or isotype-control mAbs, as previously described (31). Immuno-
precipitates were resolved by SDS-PAGE on hand-cast (12% acrylamide) or
precast gels (Criterion TGX; Bio-Rad) under nonreducing conditions. Fol-
lowing silver staining, gel images were acquired using an EPSON Perfection
1650 flatbed scanner with Microsoft Scanner and Camera Wizard (default
settings). Bands of interest were identified by comparison with control
immunoprecipitates, excised, and stored at 280˚C. In-gel reduction, deriv-
atization of cysteines with iodoacetamide, and tryptic digestion were per-
formed as previously described (31).
Peptide liquid chromatography/mass spectrometry
and calculation of protein fractional synthesis
Tryptic digests were analyzed by liquid chromatography/mass spectrometry
(LC/MS), as previously described (31), except that an LTQ Orbitrap Velos
tandem mass spectrometer (Thermo Scientific, San Jose, CA) was used.
Data were acquired in data-dependent acquisition mode. Mass spectra of
intact doubly charged or triply charged peptide ions were acquired in the
Orbitrap detector set to 7500 resolution (defined at m/z = 400). Systematic
error in mass isotopomer distributions is minimized at this resolution
(R. Busch, M.F. Usmani, P.D. Charles, and M.J. Deery, unpublished
observations) (41, 42). Tandemmass spectrometry (MS) data were acquired
after collision-induced dissociation of the five most abundant peptides in
each MS scan. Murine MHCII protein–derived peptides were identified
using the Mascot search algorithm, with a mass tolerance of 25 ppm, car-
boxamidomethylation of cysteines as a fixed modification, and methionine
oxidation as a variable modification.
For quantification of fractional protein synthesis (f), mass isotopomer
distributions of unlabeled and labeled peptides of interest were obtained by
integration of peptide ion chromatograms for the monoisotopic base peak
(m0) and higher mass isotopomers up to m2 or m3, as described previously
(31). Fractional molar abundances were calculated by normalization to the
total abundance in the mass envelope and compared with theoretical
models, which were calculated by mass isotopomer distribution analysis
(MIDA) (43), as implemented in Microsoft Excel (R. Busch, unpublished
work; available on request). Mass isotopomer distributions progressively
deviated from the unlabeled baseline during 2H2O labeling, reaching a
plateau after $10 d. The maximal (plateau) shifts from the baseline were
modeled by MIDA, using the measured body water enrichment to represent
the precursor pool enrichment and adjusting the number of biosynthetic
2H-incorporation sites (n) to minimize the root-mean-square deviation
between model and data. Fractional protein synthesis was calculated as the
percentage of the maximal possible shift of each mass isotopomer from
baseline (31). The calculations were adjusted for variations in 2H2O en-
richment between mice. Analytical error for each peptide was estimated as
an SD of two or three informative mass isotopomers and was routinely,6%,
except where mentioned. Summary estimates of fractional protein synthesis
were derived by averaging data from all available peptides (at least two),
with an overall SD, 6%. Data points with greater analytical errors, in most
cases due to low peptide ion abundance, were excluded.
DNA processing and calculation of fractional cell turnover
DNA processing and calculation of fractional cell turnover was done as
described (35), with minor modifications. Briefly, DNA-containing pellets
from extracted cell samples (see above) were boiled in deionized water,
undissolved material was removed by centrifugation, and the supernatant
was subjected to DNA hydrolysis, mild acid release of deoxyribose from
purine nucleotides, and chemical modification with pentafluorobenzyl
hydroxylamine and acetic anhydride to generate the pentafluorobenzyl
triacetyl derivative. The derivative was extracted with dichloromethane,
dried overnight in vacuo, suspended in ethyl acetate, and injected in du-
plicate into a benchtop gas chromatograph/mass spectrometer (Hewlett-
Packard). Measurements were performed in negative chemical ionization
mode, with selected ion monitoring of the ion formed by loss of HF from
the derivative, with m/z 435 (m0) or 436 (m1). The fractional molar
abundance of the m1 mass isotopomer [= m1/(m0+m1)] was calculated for
all samples by integration of the major peak, representing the trans isomer
of the derivative, in extracted ion chromatograms, using a previously de-
scribed algorithm (44) in a MatLab implementation (M.C. Varley, un-
published observations). Unlabeled deoxyribose standards spanning the
abundance range of samples were run, and abundance-corrected baseline
values (35) were subtracted to generate excess m1 (Em1) values. Bone
marrow harvested from femurs after $10 d of 2H2O labeling of mice was
used as a fully labeled control. Em1 values for unlabeled and fully labeled
deoxyribose conformed closely to those observed in previous work (35),
and duplicate measurements of Em1 were routinely within 0.2% of the
mean. Fractional DNA synthesis was calculated as fcell = (Em1[sample]/
Em1[BM]), where [BM] refers to the average of Em1 values for fully
labeled bone marrow.
Analysis of 2H2O enrichment
Sera and media were diluted gravimetrically, and 2H2O enrichment was
quantified by isotope ratio MS, as previously described (31).
Statistics
Statistical analysis was performed using GraphPad Prism software. Means
and SD of data pooled from at least two independent labeling experiments
were used as descriptive statistics. Strain differences in immunopheno-
types were evaluated by unpaired, two-tailed Student t test. Variation
between peptides from the same protein sample was analyzed by one-way
ANOVA. Two-way ANOVAwas used to analyze the effects of cell lineage
(B cell or DC) and either molecules/strains (Ag7 in NOD versus H2-Ad
[Ad] in BALB/c versus H2-Ed [Ed] in BALB/c) or sex of NOD mice. The
time course of f was modeled for each molecule or cell population as
either a single-exponential rise to maximum [f(t) = 1 2 e2kt], with rate
constant k and t1/2 = ln (2)/k or as the sum of two single-exponential
terms, with rate constants k1 and k2, weighted in relative proportions
w1 and w2 [f(t) = w1(1 2 e
2k1t) + w2(1 2 e
2k2t)], by nonlinear least-
squares fit to the data. Best-fit half-lives were reported with 95% confi-
dence intervals. Curve fits using alternative models were compared using
the F test. In addition, the F test was used to compare single-exponential
half-lives between different molecules/strains or sexes. Kaplan–Meier
analysis of cumulative disease incidence was performed, and incidence
curves were compared by the log-rank test.
Results
Use of SINEW for measurement of MHCII protein turnover
in vivo
We used the recently developed SINEWapproach to address the role
ofMHCII turnover in NOD autoimmunity in vivo (31). SINEWuses
MS to quantify the relative abundances of peptide mass variants
(“mass isotopomers”, differing by $1 Da as the result of the pres-
ence of stable isotopes of any element at any position in the peptide).
The resultant mass isotopomer distributions change upon 2H in-
corporation into proteins during continuous biosynthetic labeling
with heavy water (2H2O), in proportion to the cumulative fraction of
old molecules that has been replaced by new ones during the la-
beling interval (31). This measure, also known as fractional protein
synthesis, equals protein turnover, provided that cell turnover is
The Journal of Immunology 5963
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negligible and levels of proteins of interest remain at steady state
(Fig. 1A); these assumptions are tested further below.
The experimental design is summarized in Fig. 1B; steps a–d
represent the measurement of fractional protein synthesis. Six-
week-old female, prediabetic NOD and control mice (BALB/c:
H2-Ad and -Ed) were labeled in vivo with 2H2O for several weeks
(Fig. 1B, step a). 2H enrichments in body water were kept at ∼4–
5% throughout the labeling period, as verified by MS analysis of
sera (Fig. 1C, data not shown).
Animals were sacrificed after various times; splenocytes were
dissociated enzymatically andused for sequentialMACS isolation of
DCs (CD11c+) and B cells (B220+; Fig. 1B, step b). Flow cytometric
enumeration of APCs before MACS enrichment revealed strain
differences in APC composition (Fig. 2A–C). Spleens of young
NOD females contained significantly greater proportions and ab-
solute numbers of DCs, smaller proportions of B cells, and, thus,
a higher ratio of DCs/B cells than were found in age- and sex-
matched BALB/c mice. This was consistent with previous reports
of lymphopenia and abnormal B cell development in NOD mice
(45, 46). Despite these differences, DCs and B cells from both
strains were successfully enriched to .90% purity by MACS (Fig.
2D, 2E). Indeed,.95% of MHCII+ cells were of the desired lineage
after enrichment (Fig. 2D, data not shown).
Next, MHCII molecules were immunoprecipitated from detergent
extracts ofAPCs, using allele-specificmAbs (Fig. 1B, step c).MHCII
a2 and b-chains were separated by nonreducing SDS-PAGE and
excised following silver staining (Fig. 3A). Tryptic digests were used
for peptidemapping by tandemMS, which confirmed the presence of
the MHCII molecules of interest (Fig. 3B). Mass isotopomer dis-
tributions of selected peptides were then quantified by LC/MS (31).
An example is shown in Fig. 4A. The mass heterogeneity at baseline
is largely explained by the random incorporation of [13C] (∼1.09%
of total carbon in nature), with smaller contributions from other
stable isotopes, which are less abundant in nature. During 2H2O
labeling, 2H incorporation shifted this baseline distribution toward
heavier species, until a plateau was reached after $10 d of label-
ing, representing complete turnover of MHCII proteins. Both the
unlabeled and fully labeled mass isotopomer distributions corre-
sponded closely to theoretical predictions (Fig. 4A; see Refs. 31,
43 for details of the MIDA algorithms used). Informative peptides
were selected for each of the MHCII molecules of interest, based
on their total ion abundance, absence of peak contamination,
agreement with MIDA predictions, and the magnitude of the shifts
in the mass isotopomer distributions following 2H2O labeling. The
peptides are shown in bold type in Fig. 3B; their mass isotopomer
distributions and labeling statistics are summarized in the sup-
plemental material (Supplemental Fig. 1, Supplemental Table I).
Previous work showed that, in partially labeled mass isotopomer
distributions of peptides, the abundance of each individual mass
variant is intermediate between unlabeled and fully labeled dis-
tributions, in proportion to the fractional synthesis of the protein of
origin (31). On this basis, fractional synthesis values were cal-
culated from multiple MHCII-derived peptides. Fig. 4B shows an
analysis of B cells from individual mice labeled for 4 h. Within
error, analysis of different peptides from the same MHCII mole-
cule gave indistinguishable estimates of fractional protein syn-
thesis (Fig. 4B). Subsequently, at least two informative peptides in
each sample were analyzed, and fractional protein synthesis values
were averaged (SD # 6%).
Effect of cell lineage on the turnover of different MHCII
molecules in inbred mice
Fig. 4C summarizes the fractional synthesis of Ed, Ad, and Ag7 at
4 h for B cells, as well as DCs. Strikingly, all three MHCII mole-
cules turned over much more actively in DCs than in B cells (Fig.
4C); these differences were more pronounced than those between
MHCII molecules. Moreover, the allelic differences also depended
on the APC type: in DCs, Ag7 had higher turnover than Ed or Ad,
FIGURE 1. Measurement of MHCII turnover
in vivo by SINEW. (A) Fractional protein synthesis,
measured by SINEW, includes potential contributions
from protein turnover, net protein synthesis, and cell
proliferation. The latter contributions can be corrected
for by quantifying steady-state protein levels and
fractional DNA synthesis or neglected if they are
small. (B) Work flow for measurements of fractional
MHCII protein and DNA synthesis in APC pop-
ulations of 2H2O-labeled living mice. See text for
details. (C) Equivalent 2H2O labeling of NOD and
BALB/c mice. 2H2O a.p.e. was measured by isotope
ratio MS in serum from 6-wk-old female BALB/c
(n = 15) and NOD (n = 16) mice after up to 24 h of
2H2O labeling. Therewas no significant difference in
average 2H2O labeling between strains (p . 0.05,
Student t test). Serum 2H2O enrichments after 24 h
(data not shown) were similar, on average, but less
variable than at the earlier time points.
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but in B cells, Ed turnover was similar to Ag7 and faster than Ad.
We concluded that structural polymorphism is not the sole de-
terminant of MHCII turnover in vivo, whereas the cell lineage is a
major determinant.
When tracked over time, MHCII protein fractional synthesis in
B cells increased continuously, approaching 100% replacement of
old molecules within a week (Fig. 5A, 5B; statistics are summa-
rized in Fig. 5C). Single-exponential curve fits indicated average
fractional synthesis t1/2 ∼10–12.5 h. Consistent with data obtained
at 4 h, the half-lives for Ag7 and Ed were slightly, but significantly,
shorter than for Ad (Fig. 5C; compared by F test). Interestingly,
however, data for Ag7 turnover deviated significantly from a sin-
gle-exponential model with a uniform half-life (by Runs test) and
were significantly better modeled by a mixture of fast- and slow-
turnover subpopulations (Fig. 5B, 5C). The fast phase explained
the difference between Ad and Ag7 at 4 h, which disappeared later
in the experiment. Thus, fast turnover appears to be characteristic
of only a fraction of Ag7 molecules.
In contrast, turnover of Ag7 in M12 B lymphoma transfectants
labeled in vitro was uniformly slow, without evidence of a fast
phase (Supplemental Fig. 2) (31). Thus, the presence of kinetic
heterogeneity seemed to depend on the cellular context.
Fractional synthesis is a measure of MHCII protein turnover
in vivo
In addition to the need to replace turned-over protein, another
reason for the synthesis of new cell-associated molecules could be
the requirement to maintain steady-state protein levels as cells
divide (Fig. 1A). To assess whether cell division contributed
substantially to the need for MHCII protein synthesis, fractional
DNA synthesis was quantified by 2H2O labeling, using previously
established, well-validated methods (Fig. 1B, steps e and f) (35).
As expected, B cell proliferation occurred on much slower time
scales (t1/2 ∼2 wk) than did MHCII fractional synthesis (Fig. 5A,
5B). DC renewal was faster (data not shown), but it did not
contribute substantially to protein synthesis at early time points
(#3% new cells at 4 h). Thus, proliferative cell renewal did not
contribute substantially to the observed rates of MHCII fractional
synthesis in vivo. In contrast, Ag7 fractional protein synthesis in
the M12 B lymphoma line was entirely attributable to cell growth,
with no detectable additional contribution from protein turnover
FIGURE 2. Purification of splenic APC populations from 2H2O-labeled
NOD and BALB/c mice. (A and B) Flow cytometric analysis of enzy-
matically dissociated whole splenocytes for MHCII and lineage markers of
either B cells (CD19; upper panels) or DCs (CD11c; lower panels).
Representative dot plots (A), percentages (B, left panels), and absolute cell
counts (B, right panels) are shown (mean 6 SD, n = 16/strain; p values by
Student t test). (C) Ratio of percentage of splenic DCs/splenic B cells
(BALB/c, n = 21; NOD, n = 17; p value by Student t test). (D and E) Purity
of MACS-enriched APC populations. Sequential AutoMACS isolation of
splenic B220+ B cells (upper panels) and CD11c+ DCs (lower panels) was
monitored. Representative dot plots (D) and percentages (E) of enriched
populations are shown. Purity was routinely .90% lin+ H2-A+ (right
panels), and .95% of H2-A+ cells were of desired lineage. Spleens were
obtained from female NOD (n = 16) and BALB/c (n = 15) mice, aged 5–6
wk, and labeled for up to 24 h. Similar data were obtained after extended
2H2O labeling (data not shown).
FIGURE 3. Isolation and peptide mapping of MHCII molecules. (A)
MHCII molecules were immunoprecipitated with 14-4-4S, IgG2a anti–H2-
Ed (left panel), MK-D6, IgG2a anti–H2-Ad (center panel), and OX-6, IgG1
anti–H2-Ag7 (right panel) and either protein A– or protein G–Sepharose
from BALB/c or NOD splenic B cells (2–3 3 107), resolved by SDS-
PAGE under nonreducing conditions, and visualized by silver staining.
MHCII a- and b-chain bands (*) were identified by comparison with
controls (isotype-matched irrelevant Ab) or irrelevant cells (A20, mouse B
lymphoma line; Priess, human B-lymphoblastoid line) and excised for
tryptic peptide mapping. Note that, although both chains of the ab het-
erodimer are present in equimolar amounts, the H2-Aa-chain stained
better with silver. Each panel represents an independently acquired gel
image. (B–E) Tryptic peptide mapping. Bands of interest from (A) were
digested with trypsin and analyzed by tandem MS, and peptides were
identified by database searches. Amino acid sequences of mature Ed
a-chain (B), Ad/g7 a-chain (C), Ad b-chain (D), and Ag7 b-chain (E)
were obtained from the Uniprot database (accession numbers are shown in
brackets) and given in single-letter code. Underlined tryptic fragments
were detected by tandem MS. The symbols ˇ and * indicate positions of
complete and partial cleavage sites, respectively, where not evident from
underlining. Structural polymorphisms distinguishing Ad and Ag7 b-chains
are shown in red; dashes indicate amino acid deletion. Peptides shown in
bold were used for measurements of fractional protein synthesis.
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(Supplemental Fig. 2). We estimated that the half-life for Ag7
turnover was $42 h in this cell line.
In addition, we considered the possibility that a proportion of
splenic B cellsmight be activated in NODB cells and that thismight
contribute to heterogeneous Ag7 turnover (47). As a positive con-
trol, upregulation of MHCII, CD86, and other activation markers
was readily detected on B cells stimulated in vitro with LPS over
a wide dose range (data not shown). However, flow cytometric
analysis of MHCII (Fig. 6A, 6B) and CD86 (Fig. 6C, 6D) ex vivo
showed no evidence of B cell activation or heterogeneous MHCII
expression. In addition, these experiments showed no evidence of
inadvertent activation of APCs in vivo due to the i.p. bolus injection
of 2H2O used to initiate labeling. Pilot experiments revealed the
presence of low levels of LPS in some batches of 2H2O, which were
sufficient to cause slight activation of APCs in vitro (A. De Riva,
unpublished observations). To avoid the possibility that LPS acti-
vation could confound the turnover measurements, LPS was rou-
tinely removed from 2H2O preparations used for i.p. bolus
injection. Lastly, there was no evidence for changes in MHCII
levels over the course of the labeling experiments (Fig. 6A, 6B,
data not shown), arguing against the possibility that some of the
measured new synthesis might be attributable to net accumulation
of new MHCII molecules (Fig. 1A). Taken together, these addi-
tional controls showed that changes in MHCII levels and cell
proliferation did not contribute markedly to fractional MHCII
protein synthesis, implying that fractional synthesis is equivalent
to protein turnover in this system (Fig. 1A).
Biological variables affecting the accelerated turnover of
Ag7 molecules in NOD mice
Further experiments were undertaken to identify determinants of
the difference in turnover between H2-Ad in BALB/c B cells and
FIGURE 4. Measurement of fractional MHCII protein synthesis and
comparison in B cells and DCs after 4 h of in vivo labeling. (A) Mass
isotopomer distributions of a typical peptide from Ed a-chain are shown,
by way of example, at baseline (“unl”) and after labeling of BALB/c mice
to plateau (14 d; “lab”). Predicted distributions (“model”) were obtained
by MIDA calculations and compared with measurements by LC/MS
(“obs”). The mass variant (mass isotopomer) containing only the lightest
isotopes of each element is designated “m0”; m1, m2, and m3 have 1, 2, or
3 extra Da from incorporation of one or more heavier isotopes of any
element. The fractional molar abundance of each mass isotopomer is
shown. Fractional synthesis in partially labeled samples is calculated by
interpolation between the unlabeled and fully labeled distribution, aver-
aged across all informative mass isotopomers. (B) Indistinguishable esti-
mates of fractional synthesis obtained by analysis of different peptides
from the same MHCII protein. Fractional MHCII protein synthesis was
quantified in B cells isolated after 4 h of 2H2O labeling in vivo. Data are
shown for different peptides (identified by the first three amino acids in
each sequence; compare with Fig. 3B) from individual animals. Data were
pooled from at least two independent labeling experiments for each strain.
Fractional synthesis estimates from different tryptic fragments of the same
protein were statistically indistinguishable (p . 0.05, one-way ANOVA).
(C) APC lineage and mouse strain affect MHCII turnover at 4 h in vivo.
The fraction of new MHCII molecules is shown after 4 h of 2H2O labeling
of female, 4–6-wk-old mice. Mean 6 SD are shown for splenic B220+ B
cells from eight (Ed) or nine (Ad) individual BALB/c mice and five NOD
mice, as well as for CD11c+ DCs from five BALB/c mice and two inde-
pendently labeled pools of three NOD mice. Fractional synthesis was
averaged from two or three mass isotopomers of two to seven MHCII-
derived peptides/animal. Data from at least two independent labeling
experiments/group were pooled. Effects of APC lineage (p , 0.0001) and
molecules/strains (p , 0.0001) on turnover, as well as their mutual in-
teraction (i.e., the hierarchy of molecules depends on the cell type: p =
0.0175), were significant (two-way ANOVA). The p values in the Figure
show significant differences between molecules within each cell lineage
(Bonferroni posttest). n.s., Not significant.
FIGURE 5. Time course of MHCII protein fractional synthesis and
DNA turnover in B cells. (A) Fractional synthesis of H2-Ad and Ed and of
DNA (cell turnover) in BALB/c B cells over time. Note log scale for la-
beling times. Symbols represent mean 6 SD fractional synthesis from 1–9
animals/time point (protein data from 19 mice in total analyzed for Ad and
14 mice for Ed, pooled from two independent experiments). Lines are
single-exponential curve fits. Cell turnover was slow (t1/2 ∼ 420 h). (B)
Fractional synthesis of Ag7 and DNA in NOD B cells over time. Analysis
as in (A) (n = 20 mice, pooled from two independent experiments). Mono-
and biexponential (two-population) curve fits are shown. Cell turnover was
slow (t1/2 ∼ 290 h). (C) Kinetic parameters and statistics for the curve fits
in (A) and (B).
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Ag7 in NOD B cells at early time points. If this difference reflects
an inherent structural defect of Ag7, then it should be detectable in
(NOD 3 BALB/c) F1 mice. However, Ad and Ag7 isolated from
F1 B cells showed equal turnover at 4 h (Fig. 7A). The two
molecules were not mutually contaminated, as judged by analysis
of tryptic digests (Supplemental Table II); F1 B cells were highly
pure and not activated, as judged by analysis of MHCII and CD86
expression (Fig. 7B–D). Thus, the turnover difference between Ad
and Ag7 in the parental strains is not determined by the allelic
difference but by the context in which the H2-A molecules is
expressed.
In contrast, developmental variables affected Ag7 turnover in
NOD B cells. Turnover was indistinguishable between males and
females, both at 4 h and in B cells over time (Fig. 8A, 8B), but it
declined by 12 wk of age to rates similar to Ad turnover in young
BALB/c mice (Fig. 8C).
To address the role of environmental variables in the regulation
of MHCII turnover, Ag7 turnover at 4 h in splenic B cells from
young female mice was compared between two NOD colonies
housed in different animal facilities (Fig. 9). In the colony used for
the previous experiments, ∼22% of females developed T1D by 30
wk of age, which is at the low end of the range of disease pene-
trance observed worldwide (“NODlow”, Fig. 9A) (26). In contrast,
as many as 91% of the females in the second (“NODhigh”) colony
developed diabetes. Unlike the NODlow colony, Ag7 in B cells
from young female NODhigh animals showed no evidence of ac-
celerated turnover at the informative 4-h time point (Fig. 9B). The
purity of MACS-enriched NODhigh B cells (Fig. 9C), their non-
activated phenotype (Fig. 9D, 9E), and B cell subset composition
(data not shown) were similar to NODlow animals (Fig. 6). To-
gether, these data show that environmental differences affect Ag7
turnover in apparently nonactivated B cells. Interestingly, Ag7
turnover was not accelerated in the high-incidence colony (Fig.
9A, 9B), indicating that accelerated turnover was dispensable for
the development of T1D.
Discussion
To our knowledge, this study reports the first measurements of
MHCII protein turnover in living mice. Moreover, this study pro-
vides evidence against the hypothesis that an intrinsic stability de-
fect in Ag7 contributes to the pathogenesis of autoimmune diabetes.
The SINEW approach, previously validated to measure MHC
protein synthesis in cultured cell lines (31), was used in this study
in vivo to compare the turnover rates of different MHCII mole-
cules in NOD and control mice. The studies were carefully con-
trolled to avoid perturbation of the system by LPS contamination
during 2H2O label administration. There was no evidence for
perturbation of APCs by 2H2O itself. Measurements of the pro-
liferative renewal of APCs and of MHCII levels showed that
protein turnover was the only significant contributor to MHCII
fractional synthesis. In principle, cell turnover could be a con-
founding variable in measuring the turnover rates of long-lived,
cell-associated proteins, yet this is rarely considered in kinetic
proteomics experiments. The ability of 2H2O to label both newly
synthesized proteins and DNA (the latter representing cell turn-
over) represents a distinct advantage of SINEW over SILAC. The
SINEW measurements were analytically precise and accurate, as
judged by the close agreement of data with MIDA predictions.
The measurements were validated by analysis of multiple peptides
from each MHCII molecule. SINEW relies on quantitative shifts
in peptide mass isotopomer distributions following 2H2O labeling;
these shifts are subtler than the larger mass shifts created in
SILAC by use of all-[13C]-labeled amino acids. Nonetheless, the
analytical characteristics of the SINEW approach permitted small
differences in MHCII protein turnover to be detected.
Key determinants of MHCII protein turnover in vivo were
identified. APC type had a substantial effect. In DCs, the ∼40%
replacement of old by new molecules after 4 h of labeling cor-
responds to an average t1/2 ∼5–6 h, about twice as fast as that
observed in B cells (t1/2 ∼10–12 h). These findings correlate with
recent studies, showing that murine DCs have higher rates of
FIGURE 6. 2H2O labeling does not perturb
MHCII or CD86 expression. (A and B) Analysis
of MHCII surface levels. Representative flow
cytometry graphs (A) and median fluorescence
intensities (MFI) (B) of Ad (MK-D6) and Ag7
(OX-6) levels on gated splenic B220+ B cells (left
panels) or CD11c+ DCs (right panels) from five
BALB/c mice (top panels) and six NOD mice
(bottom panels) given 2H2O (+) and two NOD
mice and one BALB/c mouse given natural-
abundance saline (-), sacrificed up to 24 h post-
injection. 2H2O labeling had no effect (p. 0.05, t
test). Isotype control MFI values averaged ∼100
in both strains. Results are representative of all
experiments, at all time points. (C and D) Anal-
ysis of CD86 levels. Representative flow cytom-
etry graphs (C) and MFIs (D; mean 6 SD)
showing CD86 staining of mock-injected or
2H2O-labeled splenic CD19
+ B cells or CD11c+
DCs from BALB/c or NOD mice. Numbers of
animals were as in (B). Negative controls in (C)
were gated on CD3+ cells. Splenocytes from the
two strains were stained on different days, so that
MFI values are not directly comparable between
strains. CD86 levels were monitored in all ex-
periments, and the lack of 2H2O effect was con-
sistent throughout.
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ubiquitin-dependent MHCII internalization than do B cells in vitro
(17); this is thought to regulate lysosomal degradation of MHCII
molecules. MHCII turnover was much slower still (t1/2 $ 42 h) in
transfected M12 B lymphoma cells. Thus, some immortalized cell
lines, which are useful in studying other aspects of Ag presenta-
tion, are poor models for studying the physiological regulation of
MHCII protein turnover.
In B cells, the early kinetics of H2-A turnover measured by
SINEW in vivo was comparable to the kinetics observed previously
in vitro by pulse-chase analysis of unseparated splenocytes for up to
8 h (13). This was expected, given that B cells dominated quan-
titatively among splenic APCs in both mouse strains. However,
possible confounding effects of APC composition must be con-
sidered when interpreting turnover measurements in whole
splenocytes. We found that NOD spleens contain a higher ratio of
DCs/B cells than do BALB/c spleens. Therefore, the higher
MHCII turnover in DCs might have added to the differences in
total splenic MHCII turnover between these strains, although
model calculations suggest that this effect is not large (data not
shown).
Conceivably, subpopulations within the DC or B cell lineage
might also differ in MHCII protein life span. B cell subsets differ in
their ubiquitin-dependent regulation of MHCII expression (47) and
in their expression of DO, a regulator of DM-mediated peptide
exchange (23, 25). This could affect peptide loading, with possible
implications for MHC protein stability (22). However, Ad- and Ed-
labeling kinetics in BALB/c B cells conformed closely to a single-
exponential curve fit, suggesting that the turnover rates of these
molecules in the major B cell subsets are fairly uniform. None-
theless, rare subsets could exhibit distinct rates of turnover.
In vitro, activation of APCs by proinflammatory stimuli is a
major regulator of MHCII protein turnover. This is clearly evident
in LPS- and cytokine-stimulated human and murine DCs, which,
following an initial burst of MHCII synthesis, shut down ubiquitin-
dependent MHCII internalization and degradation to enable per-
sistent Ag presentation (19). The resultant shutdown in MHCII
turnover is readily observed in vitro in LPS-stimulated human
DCs by our SINEWapproach (C. Prevosto, R. Busch, unpublished
observations). In our studies, there was no evidence for activation
of B cells or DCs in the spleens of 2H2O-labeled mice when an-
alyzed ex vivo; as a positive control, MHCII, CD86, and other
activation markers were upregulated in splenic B cells stimulated
with LPS in vitro (data not shown). We concluded that the MHCII
turnover rates observed in vivo represent nonactivated conditions;
the impact of APC activation will be an interesting direction of
further research.
Compared with the large differences in MHCII turnover between
APC types, the differences between MHCII molecules were less
pronounced. In B cells and in DCs from inbred strains, initial
measurements revealed slightly faster turnover rates for Ag7 than
for Ad, reproducing the direction of trends observed previously
FIGURE 7. Indistinguishable turnover of Ad and Ag7 in B cells from
(BALB/c 3 NOD) F1 mice. (A) Fractional protein synthesis of Ag7 (n = 5
mice) and Ad (n = 4 mice) at 4 h in splenic B cells of 6-wk-old female
(BALB/c 3 NOD) F1 mice. Data were pooled from two independent
experiments. Parental strains (from Fig. 4C) are shown for comparison.
The p values were calculated using one-way ANOVA. (B) B cell purity in
the analyses shown in (A). Representative flow cytometry dot plots of
CD19 versus H2-Ad/g7 expression (stained with the cross-reactive 39-10-8
mAb) on total splenocytes (left panel) and purified B cells (right panel).
Lack of B cell activation in F1 mice, as assessed by flow cytometric
analysis of MHCII (C) and CD86 (D) expression gated on CD19+ B cells in
total splenocytes. Representative flow cytometry graphs (left panels; dark
line: 2H2O-labeled; light line: natural-abundance control; filled graphs:
negative controls). Isotype controls were used for class II stains in (C);
negative control population for CD86 was gated on CD3+ cells in (D).
Median fluorescence intensities (mean 6 SD) for six 2H2O-injected F1
mice and one normal saline-injected control mouse (right panels). There
was no evidence for phenotypic activation with or without 2H2O.
FIGURE 8. Sex and age effects on Ag7 turnover in NOD mice. (A and B)
No sex effect on Ag7 fractional synthesis. (A) Analysis of B cells (n = 3)
and DCs (n = 1) from male NOD mice at 4 h compared with females
(reproduced from Fig. 4C). The effect of cell type was significant (p ,
0.0001); the effect of sex was not significant (p = 0.74; two-way ANOVA).
(B) Analysis of B cells over a labeling time course, as in Fig. 5. The best
single-exponential curve fit (t1/2 = 10.5 h, 95% confidence interval: 9.4–
11.9 h) was not significantly different from females (p = 0.79, F test). The
data for males (n = 9 animals analyzed at five time points) were insufficient
for a biexponential curve fit. (C) Ag7 turnover at 4 h in purified splenic B
cells of 6-wk-old (from Fig. 2A) versus 12-wk-old (n = 3) female NOD
mice. The p value was calculated using the Student t test.
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in vitro (13). Albeit statistically significant and consistent within
and between experiments, the difference was ∼20% or less,
whether it was measured at a single informative time point or in
terms of average half-lives calculated from single-exponential
curve fits. Moreover, in B cells, the turnover of protective H2-E
molecules was indistinguishable from that of the Ag7 suscepti-
bility allele. Thus, differences in overall turnover rates were minor
and did not correlate with the contributions of different MHCII
molecules to T1D risk. This is consistent with our serological
studies (described above, and A. De Riva, unpublished observa-
tions), which provide no support for the notion that Ag7 is de-
fective in surface expression compared with other MHCII alleles.
However, the time course data for NOD B cells revealed another
possibility: they implied that Ag7 turnover rates are heterogeneous,
with significant populations of both long-lived and short-lived
molecules, compared with the uniform half-life of Ad. The clear
difference between Ad and Ag7 seen at early time points became
undetectable later in the experiment; a biexponential model fit the
data better than did a model with uniform half-life. It was con-
ceivable that this kinetic heterogeneity might have pathogenic
significance. Therefore, further experiments were undertaken to
characterize the fast-turnover Ag7 molecules. These studies fo-
cused on the 4-h time point, at which strain differences attributable
to the fast-turnover kinetic component were clearly detectable.
Several observations indicated that the fast-turnover Ag7 sub-
population did not arise from an intrinsic stability defect of the
Ag7 allele. First, an intrinsic defect would predict a uniformly fast
rate of Ag7 turnover, but a single-exponential labeling curve with
a short half-life was inconsistent with our data. Second, Ad and
Ag7 turnover were indistinguishable in B cells from H2d3g7 F1
mice, showing that, in one and the same cellular environment, the
17-aa differences between these alleles have no detectable effect
on turnover. Third, the turnover rate of Ed was similar to that of Ad
in DCs, but it was similar to Ag7 in B cells, indicating that the
cellular context influences relative turnover rates of different
MHCII molecules. An overriding effect of the cellular microen-
vironment was indicated by the fact that the Ag7 molecules in the
M12 B lymphoma transfectant were uniformly long-lived. Male
and female NOD mice had similar Ag7 turnover; however, the
accelerated turnover at 4 h was not observed in older NOD mice,
and it was not present in B cells from a second colony of NOD
mice housed under different environmental conditions. This re-
sponsiveness to developmental and environmental variables ar-
gued that Ag7 turnover is not determined by any intrinsic stability
defect.
The environmental regulation of MHCII turnover contrasts with
the marked influence of structural polymorphism on the SDS sta-
bility of different H2-A alleles, noted previously by other inves-
tigators (13). Our results imply that MHCII turnover rates and SDS
stability may be discordantly regulated, so that SDS instability does
not necessarily predict a shortened MHCII life span.
We considered the possibility that cellular heterogeneity could
contribute to the kinetic heterogeneity of Ag7 molecules in NOD
B cells. Preliminary experiments showed no difference in Ag7
turnover at 4 h between MACS-isolated total B220+ B cells and
FACS-sorted follicular B cells (data not shown). Moreover, the
difference in Ag7 turnover between the two colonies of NOD mice
was not explained by differences in phenotypic activation of
splenic B cells (which was undetectable in both colonies) or in
their subset composition (data not shown). These experiments do
not rule out cellular heterogeneity as a contributing variable. Al-
ternatively, heterogeneous Ag7 turnover could arise from hetero-
geneous editing of the bound peptide repertoire. This possibility is
difficult to address directly with our current methodology, which is
not able to measure the turnover rates of specific peptide/MHCII
protein complexes. Regardless of the underlying mechanisms, our
data indicate that environmental and developmental factors mod-
ify the handling of MHCII molecules in splenic B cells, even in
the absence of overt phenotypic activation.
Collectively, our studies argue strongly against a disease-
promoting role for accelerated turnover in the mechanisms link-
ing the Ag7 allele to T1D pathogenesis, which was postulated
earlier (9, 13). As argued above, the complex dynamics of Ag7
turnover in NOD spleens was determined by environmental and
developmental variables, rather than by MHCII polymorphism;
thus, it did not offer a link between MHCII polymorphism and
disease. It had only a small effect on average molecular life spans
and no discernible effect on the steady-state expression of Ag7,
limiting its potential impact on T cell tolerance. Most importantly,
accelerated turnover of some Ag7 molecules in splenic B cells was
observed only in a NOD colony with low T1D incidence and not
FIGURE 9. Lack of accelerated Ag7 turnover in B cells in a second
colony of NOD mice with high T1D incidence. (A) Kaplan–Meier analysis
of T1D incidence in female mice as a function of age in the NODlow (n =
85) versus the NODhigh (n = 45) colony. The p value was calculated using
the log-rank test. (B) Ag7 turnover in splenic B cells at 4 h differs between
6-wk-old female mice from the NODlow and NODhigh colonies. Data from
NODhigh mice (n = 6, pooled from two independent experiments) were
compared with those for NODlow and BALB/c controls (from Fig. 4C) by
one-way ANOVA. (C) Representative dot plot of CD19 versus MHCII
expression in total splenocytes (left panel) and purified B cells (right
panel). B cell activation was assessed by flow cytometric analysis of
MHCII (D) and CD86 (E) expression after gating for CD19+ splenocytes.
Representative flow cytometry graphs (left panels, dark line: 2H2O; gray
line: natural-abundance control; filled graphs: isotype controls/negative
population, as in Fig. 7C, 7D). Median fluorescence intensities (right
panels; mean 6 SD) for six 2H2O-injected NOD mice and one normal
saline-injected NOD mouse. There was no evidence for phenotypic acti-
vation with or without 2H2O.
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in a second colony with high disease incidence. Thus, the dynamic
abnormality was not required for T1D development in this high-
incidence NOD colony. The simplest explanation is that this
phenotype represents an epiphenomenon in T1D pathogenesis.
Although these data argue strongly against a causal role for
a generalized, inherent defect in Ag7 turnover, abnormalities in
specialized niches could prove to be relevant to pathogenesis. This
could include, for example, activated APCs in lesional tissue,
which contribute to T1D pathogenesis from an early stage, and
thymic APCs, which maintain central tolerance. The sample
requirements of SINEW experiments have not permitted analyses
of these less abundant populations. However, with regard to thy-
mic APCs, we note recent work that suggests that central tolerance
in NOD mice is not compromised by an Ag-presentation defect,
but rather is overwhelmed by a surfeit of ab over gd T cell pre-
cursors during thymic development (48).
Independently of the question of whether Ag7 turnover con-
tributes to T1D pathogenesis, the differences between the two
NOD colonies raised important questions for future research. A
key priority will be the isolation of specific environmental vari-
ables that determine the large differences in disease incidence.
We excluded genetic contamination of the low-incidence colony.
Differences in microbiological status, identified by veterinary and
in-house screening (data not shown), did not involve species
known to influence T1D incidence in NOD mice (27), and broader
differences in microbiota and minor differences in husbandry
practices could also contribute. A related question is how these
environmental variables could influence the dynamics of Ag7
turnover in splenic B cells without causing overt activation or
differences in B cell subset composition. We speculate that the
impaired intestinal barrier function of NOD mice (49) could allow
splenic B cells to be exposed to chronic, low-level stimulation by
intestinal microbiota or their products or cytokines. Extensive
further work will be required to test these possibilities.
In conclusion, these studies begin to define determinants of
MHCII protein turnover in vivo, which include APC lineage, age,
strain background, and environmental variables, but not, surpris-
ingly, allelic polymorphism. Our findings overturn the long-
standing, but controversial, hypothesis that autoimmunity in
NOD mice arises from an inherent susceptibility of the disease-
associated Ag7 allele to rapid turnover. Context, rather than struc-
tural MHCII polymorphism, determines the abnormal turnover of
a proportion of Ag7 molecules in NOD mice. In B cells, which are
essential for T1D (50) and harbor the great majority of splenic
MHCII molecules, small differences in turnover among Ad, Ag7,
and Ed do not correlate with their effects on T1D risk. Accelerated
Ag7 turnover in NOD splenic B cells declines with age before the
onset of T1D in a low-incidence NOD colony and is not observed in
a high-incidence NOD colony, indicating that fast Ag7 turnover is
not required for T1D.
Our findings have broader implications. Any effects of genetic
polymorphisms on protein turnover, as well as the role of protein
turnover in genotype/phenotype relationships, are best evaluated
in vivo, with due consideration of cellular and molecular hetero-
geneity. SINEW offers a widely applicable approach to this im-
portant problem.
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